Drug discovery
Drug discovery process
–
See how we can help you at each stage of the drug discovery process.
See how we can help you at each stage of the drug discovery process.
Target Identification and Validation
Lead Generation
Lead Optimisation
Candidate Selection
Clinical
Therapeutic areas
–
See where our science is driving breakthroughs in disease research.
See where our science is driving breakthroughs in disease research.
Neuroscience
Oncology
Immunology
Infectious Disease
Capabilities
–
Discover the expertise and resources powering our innovative research.
Discover the expertise and resources powering our innovative research.
In vitro Biology
In vivo Biology
Translational Medicine
Technology platforms
–
Learn about the platforms accelerating innovation in discovery.
Learn about the platforms accelerating innovation in discovery.
Mass Spectrometry
Spatial Biology
Microscopy
Preclinical Imaging
Modalities
–
Explore the innovative approaches shaping modern therapeutics.
Explore the innovative approaches shaping modern therapeutics.
Small Molecules
Large Molecules
New Modalities
Radiopharmaceuticals
Proprietary technology
–
Uncover unique innovations available only through our research.
Uncover unique innovations available only through our research.
Chemical Protein Stability Assay (CPSA)
Consultancy
–
Partner with our experts to advance your drug discovery project.
Partner with our experts to advance your drug discovery project.
R&D Consultancy
Collaborative R&D
Global challenges
Antimicrobial Resistance
Total-body PET
Mental Health
RNA Therapeutics
Impact
Funding
About
Working with us
Success stories
Board
Leadership
People
Careers
Resources
News
Events
Blogs
Reports
Recordings
Publications
Speak to us
Speak to us
Home
>
Resources
>
Publications
>
The future R&D landscape in non-alcoholic steatohepatitis (NASH)
The future R&D landscape in
non-alcoholic steatohepatitis (NASH)
Read the article at Drug Discovery Today
Related
Publications
Publications
27 Jun 2025
MDC Chemical Protein Stability Assay (CPSA) a novel target engagement approach
Find out more
Publications
28 May 2025
Use of microfluidics technology to model α-synuclein aggregation and seeding in Parkinson’s disease in vitro
Find out more
Publications
23 May 2025
BNA Poster 2025 Reactive Astrocytes MDC ALZ
Find out more
